Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Polomar Health Services (PMHS) Shares Outstanding (Weighted Average) (2022 - 2025)

Polomar Health Services has reported Shares Outstanding (Weighted Average) over the past 4 years, most recently at $27.8 million for Q3 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $27.8 million for Q3 2025, changed 0.45% from a year ago — trailing twelve months through Sep 2025 was $27.8 million (changed 0.45% YoY), and the annual figure for FY2024 was $27.7 million, up 5.91%.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $27.8 million at Polomar Health Services, up from $27.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for PMHS hit a ceiling of $452.5 million in Q4 2022 and a floor of $292430.0 in Q3 2022.
  • Median Shares Outstanding (Weighted Average) over the past 4 years was $27.7 million (2023), compared with a mean of $65.5 million.
  • Peak annual rise in Shares Outstanding (Weighted Average) hit 34521.44% in 2023, while the deepest fall reached 94.23% in 2023.
  • Polomar Health Services' Shares Outstanding (Weighted Average) stood at $452.5 million in 2022, then plummeted by 94.23% to $26.1 million in 2023, then grew by 5.91% to $27.7 million in 2024, then grew by 0.45% to $27.8 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $27.8 million (Q3 2025), $27.6 million (Q2 2025), and $27.7 million (Q1 2025) per Business Quant data.